Tag Archives: GSK

Healthcare Supply Chain

Healthcare Supply Chain

KHF Supply chain committee to engage KEMSA on UHC pilot supply chain

The supply chain committee of Kenya Healthcare Federation met on 19th March 2019 at KHF offices to outline the 2019 focus areas. The meeting was chaired the committee vice chair, Dr. Chris Masila and the committee director Dr. Anastacia Nyalita. In her opening remarks, Dr. Nyalita updated the committee that the Pharmacy and Poisons Board (PPB) has submitted the draft rules on regulation of parallel importation to the Ministry of Health (MoH) The Supply Chain Committee through Ministerial Stakeholder Forum has been advocating for the promotion of local manufacturers. This discussion has been taken up by Dr. Fred Matiangi’s team working under Kenya Private Sector Alliance (KEPSA) and together with Kenya Association of Manufacturers (KAM), there has been much progress made although the outcome of the discussions have not been released.


Supply Chain Committee members during the quarterly committee meeting at KHF offices

During the supply chain committee discussions, it emerged that the exact role of supply chain in the Universal Health Coverage (UHC) pilot counties was not clear, therefore the committee agreed to schedule a meeting with Kenya Medical Supply Authority (KEMSA) to gain insights into KEMSA’s role. Dr Nyalita updated the committee of the move by National Quality Control Laboratory This move will create monopoly in analysis leading to lack of efficiencies and cost effectiveness.

Mr. Kevin Saola from Nestle Kenya informed the meeting that international trade has been experiencing barriers especially in the East Africa. “an example of current trade barrier between Kenya and Tanzania where locally manufactured products must undergo bureaucratic, Tanzania Bureau of Standards (TBS) regulations. This has marked an increase in costs leading to poor competition.” Mr. Kevin Saola, Nestle.The committee’s focus areas for the year 2019 include: engaging KEMSA on UHC pilot counties’ supply chain, engage the NCQL board and the Ministry of Health on regulation and importation and engage the Ministry of Trade and EAC on export restrictions of Kenyan products Tanzania Bureau of standards.


Public Private Partnership

Public Private Partnership

“Private health sector should have code of conduct!”

“Private Health Sector should have code of conduct that govern its operations!” This was a call by the Cabinet Secretary, Ministry of Health, Hon. Sicily Kariuki to the private health sector to come up with code of conduct that will govern the way the private sector operates. The CS said this during the 10th Ministerial Stakeholder Forum, which was held on 27th February 2019. She said this while addressing the issues of Human Resource for Health, where she noted that most of the private health sector usually employ health workers whose contract has been terminated on disciplinary grounds or irregularities from the public sector. The code of conduct should also address this and the private sector be sensitized against hiring such personnel.

Public Private Partnership (PPP) committee members during the quarterly meeting

The Public Private Partnership Committee of Kenya Healthcare Federation (KHF), held their first meeting at KHF offices on 20th March 2019 to discuss and outline 2019 focus areas. There was a unanimous agreement that the committee will tap into Kenya Private Sector alliance (KEPSA) Resources and work closely with KEPSA to crystalize clear requirements for drafting the code of conduct.

Other committee’s focus areas for the year 2019 include: Mapping out PPP areas in the counties through a comparison of the various studies done by stakeholders and map out gaps identified, act as the private sector’s focal point of advisory and delivery of the Global Fund, and Draft a  position paper on bureaucratic challenges facing the Private Sector regarding involvement in Universal Health Coverage (UHC) implementation at the County level. The committee will also work with other committees on their findings on UHC in the 4 pilot counties. The committee will review the PPP Act document and its restrictions to the PPP at the county level.

China- Kenya Pharmaceutical Trade and Investment Forum

China- Kenya Pharmaceutical Trade and Investment Forum

China- Kenya Pharmaceutical Trade and Investment Forum

The China Chamber of Commerce for Import and Export of Medicines & Health Products (CCCMHPIE), held a trade and investment forum together with the Ministry of Health Kenya and the private health sector in Kenya on the 30th of August 2018 at the Laico Regency Hotel in Nairobi.

Public and Private Health sector stakeholders during China – Kenya Pharmaceutical Trade and Investment Forum

The main aim of the forum was to establish and maintain a good relationship between Kenyan and Chinese healthcare sectors and further explore investment opportunities in the Kenyan pharmaceutical industry. This forum was sponsored by UKAID and brought together participants from Ministry of Health Kenya, Pharmacy and Poisons Board Kenya, the Kenya Healthcare Federation, the Kenya Chamber of Commerce, the Economic & Commercial Counsellor’s Office at the Embassy of the People’s Republic of China, and the China Africa Friendship Association.

Ms. Guo Xiaodan deputy secretary of sub-chamber, department of pharmaceutical, CCCMHPIE, opened the forum by welcoming the guests. In her opening speech, she reiterated that she’s extremely happy to visit Kenya and establish a lasting relationship between Kenyan and Chinese healthcare sectors.

CCCMHPIE was established in May in 1989. It is the most internationalized and influential healthcare industry association in China the key areas of responsibility include: policy and industry coordination, conferences and training, exhibitions registration, consulting, market surveys and analysis reports in traditional Chinese medicines, pharmaceuticals, medical devices & dressings, biopharmaceuticals and functional cosmetics.

In his speech, Mr. Tan Shengcai, head of the Chinese healthcare delegation gave a background of Kenya – China relationship especially in investment. He emphasized that Kenya has been contracting China in building and construction particularly in road construction. There is need to have deeper engagement especially in the healthcare industry. He invited the Chinese healthcare delegates to evaluate the Kenyan market and see possible investment opportunities in the pharmaceutical industry.

Dr. Amit Thakker, Chairman, Kenya Healthcare Federation welcomed the China healthcare delegation to Kenya. In his speech, he informed the attendees that the investment forum is very timely since it touches on two pillars of the BIG 4 Agenda i.e. Manufacturing and Affordable Healthcare for all. He however emphasized that there is need to bridge the gaps in healthcare drivers, such as Human Resource for Health, Healthcare financing healthcare and ICT and Mobile Health.

Dr. Amit Thakker, Chairman – Kenya Healthcare Federation speaking during the China – Kenya Pharmaceutical Trade & Investment Forum

The Pharmacy and Poisons Board was clear on their regulatory role in the practice of Pharmacy and the Manufacture and Trade in drugs and poisons. The Board aims to implement the appropriate regulatory measures to achieve the highest standards of safety, efficacy and quality for all drugs, chemical substances and medical devices locally manufactured, imported, exported, distributed, sold, or used, to ensure the protection of the consumer as envisaged by the laws regulating drugs in Kenya.

There was a B2B session thereafter conducted by CCCMHPIE where the China delegation had an impactful engagement with the Kenyan health sector, both private and public. The China delegation touched on business opportunities and engagements that can be established between Kenya and China. The Chinese team visited Kenya Medical Supplies Authority (KEMSA) thereafter.